|
Match
|
Document |
Document Title |
|
|
5185158 |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
A dosage form is provided for administering a drug of the formula ##STR1## to a patient to produce an anxiolytic benefit in the patient.
|
|
|
5178867 |
Dosage form for delivering drug in short-time period
The invention pertains to a dosage form for orally administering a drug in eight hours or less to the stomach and small intestine for a therapeutic result.
|
|
|
5178868 |
Dosage form
The invention relates to an oral pharmaceutical multiple units formulation made up of individual cores containing a pharmacologically active substance, the cores being provided with a coating...
|
|
|
5178866 |
Dosage form for delivering drug to the intestine
A drug delivery device is disclosed for delivering a drug to the intestine and the colon. The device comprises external means for delaying the delivery of drug in the stomach, and hydrophobic means...
|
|
|
5174999 |
Delivery system comprising fluid ingress and drug egress
A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the...
|
|
|
5160743 |
Annealed composition for pharmaceutically acceptable drug
A dosage form is disclosed comprising a coat that surrounds a drug. The coat comprises a subcoat and an overcoat thermally annealed to provide a single unit coat around the drug.
|
|
|
5160744 |
Verapmil therapy
A dosage form is disclosed comprising means for delaying the delivery of drug from the dosage form following the administration of the dosage form to a patient in need of drug therapy.
|
|
|
5153002 |
Biocompatible gradient controlled release implant
A biocompatible and/or biodegradable implant for the substantially constant release, by diffusion, of a therapeutic agent in the outside medium at the site of implant which comprises a body...
|
|
|
5147654 |
Oral osmotic device for delivering nicotine
An osmotic device (10) for the controlled systemic delivery of nicotine through an oral mucosal membrane of a human patient is disclosed. The device (10) has a size and shape adapting it to be...
|
|
|
5141752 |
Delayed drug delivery device
A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.
|
|
|
5135523 |
Delivery system for administering agent to ruminants and swine
A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the...
|
|
|
RE33994 |
Pharmaceutical delivery system
A composition for use in an aqueous environment which comprise comprises a formulation containing a water-soluble pharmaceutically beneficial agent, a water-insoluble, water-permeable film...
|
|
|
5128145 |
Dosage form for Parkinson's disease, spasticity and muscle spasms
A dosage form is disclosed comprising a drug and a maltodextrin polymer for administering to a patient a drug in need of therapy.
|
|
|
5126142 |
Dispenser comprising ionophore
A dispenser is disclosed for delivering a beneficial ionophore to an animal. The dispenser comprises (1) a semipermeable housing defining an internal space, (2) at least one composition comprising...
|
|
|
5126146 |
Cellulosic coating
A microporous, cellulosic coating useful in combination with osmotically controlled drug delivery devices is disclosed. In one embodiment, this coating results from application to core tablets of a...
|
|
|
5120548 |
Swelling modulated polymeric drug delivery device
A controlled release drug delivery device, comprised of swellable polymers, whose degree of swelling in an environment of use is controlled by swelling modulators blended within the polymers, is...
|
|
|
5114719 |
Extended drug delivery of small, water-soluble molecules
A polymeric device releasing biologically active, water-soluble materials having a molecular weight of less than 1000 in a controlled, continuous and linear manner over an extended period of time....
|
|
|
5110596 |
Delivery system comprising means for delivering agent to livestock
A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the...
|
|
|
5108756 |
Dispensing devices powered by lyotropic liquid crystals
This invention relates to devices useful for the controlled delivery of one or more beneficial agents to an environment of use. More specifically, this invention concerns such devices which are...
|
|
|
5102668 |
Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
A sustained-release pH independent pharmaceutical preparation having multi-units of microparticles comprising a granular drug which is less soluble at low pH and more soluble at high pH. The...
|
|
|
5098714 |
Osmotic, oral dosage form for fertility control
An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a...
|
|
|
5096716 |
Dosage form for administering calcium antagonist nicardipine
A dosage form is disclosed comprising a member selected from the group consisting of nicardipine and its pharmaceutically acceptable salts for administering to a patient in need of cardiovascular...
|
|
|
5091190 |
Delivery system for administration blood-glucose lowering drug
A dosage form is disclosed comprising the antidiabetic drug glipizide for administering to a patient in need of glipizide therapy.
|
|
|
5091175 |
Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
A pharmaceutical composition useful for treating hypercholesterolemia comprising a bile acid sequestrant resin such as cholestyramine and cholestipol maintained in a semipermeable water-insoluble...
|
|
|
5082668 |
Controlled-release system with constant pushing source
A device is disclosed comprising a wall that surrounds a compartment. The compartment comprises a beneficial agent composition and a push composition. A passageway in the wall connects the...
|
|
|
5059423 |
Delivery system comprising biocompatible beneficial agent formulation
A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the...
|
|
|
5057321 |
Dosage form comprising drug and maltodextrin
A dosage form is disclosed comprising a drug and a maltodextrin polymer for administering to a patient a drug in need of therapy.
|
|
|
5057318 |
Delivery system for beneficial agent over a broad range of rates
A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the...
|
|
|
5049395 |
Controlled release vehicle
A new controlled release vehicle which acts by breakdown of the entrapping material upon hydration has been developed. The preferred release vehicle is made of a carboxylated cellulose, e.g.,...
|
|
|
5035891 |
Controlled release subcutaneous implant
A sustained release, reservoir-type subcutaneous implant device for the sustained administration to a subject of a biologically active compound comprises: an effective amount of a biologically...
|
|
|
5035897 |
Dosage form for delivering soluble or insoluble drugs
A dosage form is disclosed comprising granule means for delivering soluble to insoluble drug to a warm-blooded animal.
|
|
|
5034229 |
Dispenser for increasing feed conversion of hog
A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the...
|
|
|
5030456 |
Dosage form for treating cardiovascular diseases
An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
|
|
|
5028434 |
Method for administering nilvadipine for treating cardiovascular symptoms
A dosage form is disclosed comprising nilvadipine for administering to a patient in need of cardiovascular therapy.
|
|
|
5024843 |
Oral hypoglycemic glipizide granulation
A dosage form is disclosed comprising the antidiabetic drug glipizide for administering to a patient in need of glipizide therapy.
|
|
|
5024842 |
Annealed coats
A dosage form is disclosed comprising a coat that surrounds a drug. The coat comprises a subcoat and an overcoat thermally annealed to provide a single unit coat around the drug.
|
|
|
5023076 |
Lamina comprising carboxyvinyl polymer
A dosage form is disclosed for delivering the beneficial drugs pseudoephedrine and brompheniramine to a biological environment of use.
|
|
|
5019396 |
Delivery dispenser for treating cardiac arrhythmias
A dosage form is disclosed comprising a first composition comprising two different polyethylene oxide osmopolymers for delivering a drug at a controlled rate over time.
|
|
|
5019397 |
Aqueous emulsion for pharmaceutical dosage form
A dosage form is disclosed comprising a cured emulsion that coat that surrounds a drug. The emulsion comprises a lower alkyl acrylate-lower alkyl methacrylate copolymer and ethyl cellulose. The...
|
|
|
5011694 |
Pharmaceutical dosage unit forms with delayed release
Improved delayed release pharmaceutical dosage unit forms such as tablets are obtained by exposing a matrix of a compressed mixture of active pharmaceutical ingredient and of a polyacrylic ester...
|
|
|
5006346 |
Delivery system
A dosage form is disclosed comprising a coat that surrounds a drug. The coat comprises a subcoat and an overcoat thermally annealed to provide a single unit coat around the drug.
|
|
|
5004614 |
Controlled release device with an impermeable coating having an orifice for release of drug
Controlled release devices having a core including an active agent and an outer coating which is substantially impermeable to the entrance of an environmental fluid and substantially impermeable to...
|
|
|
5000957 |
Dispenser comprising hydrophilic osmopolymer
A dispensing system is disclosed comprising a wall surrounding a lumen. The lumen comprises (1) a thermo responsive composition comprising a beneficial agent, (2) means for occupying space in the...
|
|
|
4996060 |
Device comprising liner for protecting fluid sensitive medicament
A delivery device is disclosed for delivering a beneficial agent to an animal. The device comprises a wall housing an internal space, a beneficial agent in the space, expandable means in the space...
|
|
|
4994273 |
Solubility modulated drug delivery device
A solubility modulated drug delivery device for controlled release of a therapeutically active ingredient into an environment of use is disclosed. The device comprises a core composition of a...
|
|
|
4992278 |
Therapeutic system for sparingly soluble active ingredients
The present invention relates to a therapeutic system with systemic action for peroral administration, having a compartment for active ingredients, which system contains in that compartment...
|
|
|
4988512 |
Nasal pharmaceutical compositions
Solid nasal inserts of calcitonin and other peptides have particularly interesting drug absorption profiles.
|
|
|
4983401 |
Sustained release pharmaceutical preparations having pH controlled membrane coatings
A sustained-release pharmaceutical preparation utilizing a pH controlled diffusion membrane composed of a pH sensitive film-forming polymer. The film forming polymer may be an enteric polymer...
|
|
|
4980171 |
Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative
The invention relates to oral pharmaceutical compositions comprising a diphosphonic acid derivative and sodium laurylsulfate in the amount of 1.5 to 6% by weight, relative to the diphosphonic...
|
|
|
4976966 |
Delayed release osmotically driven fluid dispenser
An osmotically driven pump is provided that is capable of being miniaturized to a size suited for swallowing or implanting in an animal. The pump may be used to administer a drug in fluid form...
|